Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuwiq in Chinese Patients With Severe Hemophilia A
CTR20171633Phase 3Completed
- Sponsor
- Octapharma
- Start
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Started May 2018; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20171633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171633.